Article ID Journal Published Year Pages File Type
3991556 Journal of Thoracic Oncology 2007 6 Pages PDF
Abstract
Pemetrexed was generally well tolerated with noteworthy activity in malignant pleural mesothelioma after previous platinum-based treatment and may be considered for second-line treatment.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Oncology
Preview
Pemetrexed as Second-Line Treatment in Malignant Pleural Mesothelioma after Platinum-Based First-Line Treatment
Authors
, , , , , , ,